EMA recommends marketing approval of Alvotech's Gobivaz biosimilar to Simponi

Nanjing Leads Biolabs receives FDA approval of IND application for LBL-047

J & D Pharmaceuticals receives Orphan Drug Designation for JD-004

Hemogenyx reports positive safety and early efficacy data from third patient in CAR-T trial

Forte Biosciences highlights positive FB102 data in celiac disease at Tampere Symposium

Hemogenyx Pharmaceuticals partners with Made Scientific to advance CAR-T therapy

Onco3R Therapeutics receives Belgian regulatory approval for clinical trial of novel SIK3 inhibitor

ImmuPharma files patent for P140 'Immunormalizer' with precision diagnostic for autoimmune diseases

Coya Therapeutics wins FDA clearance to advance COYA 302 into Phase 2 ALS trial

Bio-Thera and STADA expand biosimilars partnership to include tocilizumab

Abbvie completes Capstan Therapeutics acquisition

Remegen's Telitacicept meets Sjogren's syndrome Phase III trial's primary endpoint

Novartis reports positive Phase III trial results for ianalumab in immune thrombocytopenia

Novartis reports positive Phase III results for ianalumab in Sjögren's disease

US FDA approves Innovent's IND application for IBI3032 oral GLP-1R agonist